BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//INSTITUTO UNIVERSITARIO DE AUTOMÁTICA E INFORMÁTICA INDUSTRIAL - ECPv5.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.ai2.upv.es
X-WR-CALDESC:Events for INSTITUTO UNIVERSITARIO DE AUTOMÁTICA E INFORMÁTICA INDUSTRIAL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250508
DTEND;VALUE=DATE:20250510
DTSTAMP:20261102T023848
CREATED:20250220T091719Z
LAST-MODIFIED:20250220T092113Z
UID:26640-1746662400-1746835199@www.ai2.upv.es
SUMMARY:WORKSHOP ON ENGINEERING DIABETES TECHNOLOGIES
DESCRIPTION:The IFAC Workshop on Engineering Diabetes Technology is born out of the necessity of finding a space to discuss and share the latest technological advances in the area of diabetes management\, aiming to bring together senior\, young researchers\, and industry \nDiabetes is a major health issue that has reached alarming levels. According to the International Diabetes Federation (IDF)\, today more than half a billion people are living with diabetes worldwide. Diabetes is a serious long-term or “chronic” condition where high glucose levels occur either because the body is not able to produce any or enough insulin (Type 1 Diabetes\, T1D) or cannot effectively use the insulin it produces (Type 2 Diabetes\, T2D). Glycemic control in diabetes remains a challenge\, with a low portion of adults with the condition achieving an A1c target of <7%\, despite the availability of modern glucose-lowering agents\, modern insulin analogs\, the improving accuracy of glucose monitoring\, the widening use of intensive insulin therapy (IIT)\, and emerging use of closed-loop (AID) and decision support systems (DSS). While new technologies have proven benefits in avoiding diabetes-related complications and may have reduced excess mortality in some populations\, excess mortality and complication rates remain higher in people with diabetes when compared to the general population. \nThis situation continues to pose challenges to scientists and engineers in the field\, who work towards improving the life of people with diabetes\, proposing technological novelties that can be transferred to the industry and reach people affected by this disease. \nEDT is co-organized by the Instituto ai2 of the Universitat Politècnica de València (Spain)\, the University of Virginia (USA)\, and the University of Bern (Switzerland). \n  \nPARTICIPATE!
URL:https://www.ai2.upv.es/event/workshop-on-engineering-diabetes-technologies/
LOCATION:Universitat Politècnica de València\, València\, Spain
END:VEVENT
END:VCALENDAR